SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-029792
Filing Date
2019-05-15
Accepted
2019-05-15 17:26:03
Documents
13
Period of Report
2019-05-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41190_118k.htm 8-K 37703
2 EX-3.1 a18-41190_11ex3d1.htm EX-3.1 14323
3 EX-3.2 a18-41190_11ex3d2.htm EX-3.2 249944
4 EX-99.1 a18-41190_11ex99d1.htm EX-99.1 9106
5 EX-99.2 a18-41190_11ex99d2.htm EX-99.2 9345
6 GRAPHIC g4119011moi001.jpg GRAPHIC 3102
7 GRAPHIC g4119011mmi001.jpg GRAPHIC 3102
8 GRAPHIC g4119011kgi001.jpg GRAPHIC 48406
9 GRAPHIC g4119011kgi002.jpg GRAPHIC 35559
10 GRAPHIC g4119011kgi003.jpg GRAPHIC 125381
11 GRAPHIC g4119011kgi004.jpg GRAPHIC 126787
12 GRAPHIC g4119011kgi005.jpg GRAPHIC 86017
13 GRAPHIC g4119011kgi006.jpg GRAPHIC 34149
  Complete submission text file 0001104659-19-029792.txt   959674
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 19829770
SIC: 2834 Pharmaceutical Preparations